Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
This study has been completed.
Study NCT00060840.   Last updated on September 23, 2008.
Information provided by INO Therapeutics
Please refer to this study by its ClinicalTrials.gov identifier: NCT00060840
Locations
United States, New Jersey
Newark Beth Isreal Medical Center
Newark, New Jersey, United States, 07112
United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
United States, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
University of Cincinnati
Cincinnati, Ohio, United States, 45219
United States, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States, 15212
United States, Texas
Baylor University Medical Center
Dallas, Texas, United States, 75226
University of Texas/St. Paul Medical Center
Dallas, Texas, United States, 75390
Texas Heart Institute
Houston, Texas, United States, 20345
Germany, Bad Oeynhausen
Herz-und Diabeteszentrum Nordrhein-Westfalen
Gergstrab, Bad Oeynhausen, Germany, 32545
Germany, Berlin
Deutsches Herfzzentrum Berlin
Augustenburger Platz, Berlin, Germany, 13353
United Kingdom, Middlesex
Harefield Hospital
Harefield, Middlesex, United Kingdom, UB96JH
Sponsors and Collaborators
INO Therapeutics
Investigators
Study Director: James Baldassarre, MD INO Therapeutics




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services